Cannell Capital - LAVA THERAPEUTICS NV ownership

LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 17 filers reported holding LAVA THERAPEUTICS NV in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cannell Capital ownership history of LAVA THERAPEUTICS NV
ValueSharesWeighting
Q1 2023$29,805
-52.6%
17,9550.0%0.01%
-53.8%
Q4 2022$62,843
-23.4%
17,9550.0%0.01%
-31.6%
Q3 2022$82,000
+583.3%
17,955
+342.5%
0.02%
+850.0%
Q2 2022$12,0004,0580.00%
Other shareholders
LAVA THERAPEUTICS NV shareholders Q2 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 610,809$2,791,0000.94%
Novo Holdings A/S 3,327,312$15,206,0000.72%
Redmile Group, LLC 2,816,196$12,870,0000.50%
Alpha Wave Global, LP 121,193$554,0000.06%
Artal Group S.A. 200,000$914,0000.04%
Cannell Capital 17,955$82,0000.02%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 75,000$343,000,0000.01%
AXA S.A. 457,342$2,090,0260.00%
TSFG, LLC 400$2,0000.00%
OSAIC HOLDINGS, INC. 48$00.00%
View complete list of LAVA THERAPEUTICS NV shareholders